Verheij syndrome is a rare genetic disorder caused by the impairment of splicing, a critical process in RNA processing. Using the model organism Caenorhabditis elegans, researchers at the Max Planck Institute for Biology of Aging have demonstrated that this disruption affects metabolic pathways that rely on vitamin B12.
Administering vitamin B12 restored key metabolic processes in the worm model and corrected developmental anomalies in the mutated animals. Analyses of human cells and blood samples from patients revealed comparable metabolic changes.
The findings, published in the journal Nature Communications, could pave the way for targeted therapies for Verheij syndrome.
Splicing is the process by which messenger RNA is further processed before it is used to build proteins. During this process, unnecessary sections are removed and the remaining sections are correctly assembled. Disruption to this process can have far-reaching consequences for the cell, and changes to the genes involved in splicing can cause rare developmental disorders in humans, such as Verheij syndrome. Children affected by this syndrome exhibit developmental delays, growth disorders and short stature.
The study began with experiments on the nematode C. elegans aimed at identifying novel genes that influence lifespan. In the course of this work, the researchers focused on a mutation in a gene that plays an important role in splicing and is linked to Verheij syndrome in humans. Worms carrying this mutation showed characteristics that reflect key features of the disease: They grew more slowly and remained smaller.
B12 normalizes metabolic processes
Genetic screens and metabolic analyses revealed that metabolic pathways in the mutated worms were altered. These pathways rely on vitamin B12 and are important for growth and cell function. Administering vitamin B12 normalized these key metabolic processes and corrected the Verheij-like developmental defects in the mutated worms.
"We were surprised to find that a change in a fundamental process of RNA processing had such a targeted effect on vitamin B12-dependent metabolism," says Jonathan Kölschbach, first author of the study. "Even more exciting was that we were able to largely correct the consequences of this change in the worm model using vitamin B12."
The researchers also found evidence of related metabolic changes in human data. To this end, the team analyzed publicly available data from human cells and collaborated with Hormos Dafsari, a pediatric neurologist at the University Hospital Cologne, to obtain blood samples from patients with Verheij syndrome. The results suggest that the metabolic pathways identified in the worm model may also be relevant in humans.
Future studies will need to determine whether vitamin B12 can also help patients with Verheij syndrome. However, the results suggest that metabolic changes may play a more significant role in disorders involving splicing defects than previously thought. The study could therefore provide new avenues for research into potential therapies beyond Verheij syndrome.
"Our study is a good example of how basic research on model organisms can provide new insights into human diseases," says Adam Antebi, director at the Max Planck Institute for Biology of Aging and lead author of the study. "A fundamental biological question can thus give rise to a new approach that could also become medically relevant in the long term."
Publication details
Jonathan Kölschbach et al, Vitamin B12 alleviates spliceosomopathy via phospholipid remodeling, Nature Communications (2026). DOI: 10.1038/s41467-026-76295-9
Who's behind this story?
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Vitamin B12 corrects developmental defects in Verheij syndrome worm model (2026, August 10) retrieved 10 August 2026 from https://phys.org/news/2026-08-vitamin-b12-developmental-defects-verheij.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
>> Home